Darren M. Ashcroft

25.6k total citations · 7 hit papers
464 papers, 17.0k citations indexed

About

Darren M. Ashcroft is a scholar working on Geriatrics and Gerontology, General Health Professions and Emergency Medical Services. According to data from OpenAlex, Darren M. Ashcroft has authored 464 papers receiving a total of 17.0k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Geriatrics and Gerontology, 107 papers in General Health Professions and 98 papers in Emergency Medical Services. Recurrent topics in Darren M. Ashcroft's work include Pharmaceutical Practices and Patient Outcomes (116 papers), Patient Safety and Medication Errors (91 papers) and Psoriasis: Treatment and Pathogenesis (63 papers). Darren M. Ashcroft is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (116 papers), Patient Safety and Medication Errors (91 papers) and Psoriasis: Treatment and Pathogenesis (63 papers). Darren M. Ashcroft collaborates with scholars based in United Kingdom, United States and Netherlands. Darren M. Ashcroft's co-authors include C.E.M. Griffiths, Rosa Parisi, Deborah Symmons, Evangelos Kontopantelis, Peter Noyce, Richard N. Keers, Steven Williams, Denham L. Phipps, Matthew Carr and Roger T. Webb and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Darren M. Ashcroft

442 papers receiving 16.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

2012 1.9k citations Rosa Parisi, Deborah Symmons et al. profile →
National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study

2020 730 citations Rosa Parisi, Evangelos Kontopantelis et al. BMJ profile →
Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis

2019 415 citations Richard N. Keers, Aseel S. Abuzour et al. BMJ profile →
Causes of Medication Administration Errors in Hospitals: a Systematic Review of Quantitative and Qualitative Evidence

2013 342 citations Richard N. Keers, Darren M. Ashcroft et al. profile →
Incidence, clinical management, and mortality risk following self harm among children and adolescents: cohort study in primary care

2017 236 citations Roger T. Webb, Matthew Carr et al. BMJ profile →
Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study

2021 188 citations Matthew Carr, Roger T. Webb et al. profile →
Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study

2024 38 citations Matthew Carr, Bruce Guthrie et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Darren M. Ashcroft United Kingdom	63	4.8k	3.2k	2.8k	2.6k	2.4k	464	17.0k
James S. Goodwin United States	83	1.8k 0.4×	1.7k 0.5×	266 0.1×	254 0.1×	3.7k 1.5×	442	24.7k
Samy Suissa Canada	92	1.3k 0.3×	573 0.2×	288 0.1×	488 0.2×	1.3k 0.5×	491	33.5k
Jesper Hallas Denmark	61	421 0.1×	2.1k 0.7×	359 0.1×	467 0.2×	880 0.4×	476	17.4k
Lars Pedersen Denmark	69	1.3k 0.3×	390 0.1×	344 0.1×	406 0.2×	913 0.4×	353	22.8k
Toine C. G. Egberts Netherlands	72	834 0.2×	3.2k 1.0×	108 0.0×	1.2k 0.4×	716 0.3×	512	18.2k
Harvey Jay Cohen United States	75	933 0.2×	7.0k 2.2×	192 0.1×	361 0.1×	2.2k 0.9×	370	23.1k
Richard Hobbs United Kingdom	74	286 0.1×	701 0.2×	722 0.3×	548 0.2×	2.7k 1.1×	557	24.0k
Jerry Avorn United States	102	817 0.2×	5.4k 1.7×	131 0.0×	894 0.3×	5.2k 2.1×	517	38.6k
E. John Orav United States	95	589 0.1×	1.1k 0.3×	130 0.0×	2.0k 0.8×	8.0k 3.3×	446	33.5k
Daniel H. Solomon United States	96	4.1k 0.9×	824 0.3×	492 0.2×	105 0.0×	1.5k 0.6×	585	36.0k

Countries citing papers authored by Darren M. Ashcroft

Since Specialization

Citations

This map shows the geographic impact of Darren M. Ashcroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren M. Ashcroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren M. Ashcroft more than expected).

Fields of papers citing papers by Darren M. Ashcroft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darren M. Ashcroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren M. Ashcroft. The network helps show where Darren M. Ashcroft may publish in the future.

Co-authorship network of co-authors of Darren M. Ashcroft

This figure shows the co-authorship network connecting the top 25 collaborators of Darren M. Ashcroft. A scholar is included among the top collaborators of Darren M. Ashcroft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren M. Ashcroft. Darren M. Ashcroft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeffries, Mark, et al.. (2025). Understanding the implementation of a multidisciplinary intervention using a suite of prescribing safety indicators to improve medication safety in prison healthcare settings: a qualitative study. BMJ Open. 15(3). e086309–e086309. 1 indexed citations

Parisi, Rosa, et al.. (2024). Development and evaluation of an online training tool to aid in the diagnosis of chronic plaque psoriasis. SHILAP Revista de lepidopterología. 4(1). 174–180. 1 indexed citations

Camacho, Elizabeth, Amy K. Taylor, Bruce Guthrie, et al.. (2024). Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling study. BMJ. 386. e077880–e077880. 2 indexed citations

Armitage, Christopher J., et al.. (2024). Decoding behaviour change techniques in opioid deprescribing strategies following major surgery: a systematic review of interventions to reduce postoperative opioid use. BMJ Quality & Safety. 34(3). 166–177. 1 indexed citations

Schofield, Jonathan, Michael France, Darren M. Ashcroft, et al.. (2024). Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia. Frontiers in Cardiovascular Medicine. 11. 1389106–1389106. 10 indexed citations

Morris, Charlotte, et al.. (2024). Inequalities in the Quality and Safety of Post‐Diagnostic Primary Care for People With Dementia: A Scoping Review. International Journal of Geriatric Psychiatry. 39(12). e70035–e70035.

Muntyanu, Anastasiya, Mohammed Kaouache, Wayne Gulliver, et al.. (2024). Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada. American Journal of Clinical Dermatology. 25(3). 497–508. 4 indexed citations

Staa, Tjeerd van, Munir Pirmohamed, Anita Sharma, Darren M. Ashcroft, & Iain Buchan. (2023). Adverse drug reactions and hospital admissions: Large case‐control study of patients aged 65–100 years using linked English primary care and hospital data. Pharmacoepidemiology and Drug Safety. 33(1). e5681–e5681. 1 indexed citations

Pate, Alexander, Darren M. Ashcroft, Ben Goldacre, et al.. (2023). The impact of COVID-19 on antibiotic prescribing in primary care in England: Evaluation and risk prediction of appropriateness of type and repeat prescribing. Journal of Infection. 87(1). 1–11. 7 indexed citations

10.

Dempsey, J.F., Rachel Isba, Matthew Carr, et al.. (2023). Protocol for the Paediatric Otorrhoea Study (POSt): a multi-methods study to understand the burden of paediatric otorrhoea in the UK. BMJ Open. 13(9). e078052–e078052. 2 indexed citations

11.

Carr, Matthew, et al.. (2023). Non‐fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records. Addiction. 118(12). 2374–2383. 2 indexed citations

12.

Zghebi, Salwa S., David Reeves, Christos Grigoroglou, et al.. (2022). Clinical code usage in UK general practice: a cohort study exploring 18 conditions over 14 years. BMJ Open. 12(7). e051456–e051456. 6 indexed citations

13.

Rodgers, Sarah, Stephen A. Roberts, Thomas Allen, et al.. (2022). Scaling-up a pharmacist-led information technology intervention (PINCER) to reduce hazardous prescribing in general practices: Multiple interrupted time series study. PLoS Medicine. 19(11). e1004133–e1004133. 8 indexed citations

14.

Bourne, Richard S, et al.. (2022). A Delphi consensus study to identify priorities for improving and measuring medication safety for intensive care patients on transfer to a hospital ward. International Journal for Quality in Health Care. 34(4). 6 indexed citations

15.

Staa, Tjeerd van, Munir Pirmohamed, Anita Sharma, Iain Buchan, & Darren M. Ashcroft. (2022). Clinical Relevance of Drug–Drug Interactions With Antibiotics as Listed in a National Medication Formulary: Results From Two Large Population‐Based Case‐Control Studies in Patients Aged 65–100 Years Using Linked English Primary Care and Hospital Data. Clinical Pharmacology & Therapeutics. 113(2). 423–434. 1 indexed citations

16.

Phipps, Denham L., Hanne Herborg, Mara Pereira Guerreiro, et al.. (2011). Evaluation of the Pharmacy Safety Climate Questionnaire in European community pharmacies. International Journal for Quality in Health Care. 24(1). 16–22. 17 indexed citations

17.

Saad, Amr, Darren M. Ashcroft, Kath Watson, et al.. (2009). Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register. Arthritis Research & Therapy. 11(2). R52–R52. 166 indexed citations

18.

Elvey, Rebecca, Darren M. Ashcroft, F. H. Bradley, et al.. (2005). Setting up local pharmaceutical services: lessons for primary care trusts. Pharmaceutical journal/The pharmaceutical journal. 274(7348). 546–548. 1 indexed citations

19.

Ashcroft, Darren M., Paul W. Dimmock, Ruth Garside, Ken Stein, & Hywel C Williams. (2005). Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ. 330(7490). 516–516. 169 indexed citations

20.

Chen, Li‐Chia, Rachel Elliott, & Darren M. Ashcroft. (2004). Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control. Journal of Clinical Pharmacy and Therapeutics. 29(3). 215–229. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact